Anticoagulation for atrial fibrillation ablation: What is the optimal strategy?

Bradley P. Knight*

*Corresponding author for this work

Research output: Contribution to journalEditorialpeer-review

17 Scopus citations
Original languageEnglish (US)
Pages (from-to)1175-1177
Number of pages3
JournalJournal of the American College of Cardiology
Issue number13
StatePublished - Mar 27 2012


  • anticoagulation
  • atrial fibrillation ablation
  • dabigatran
  • matched case-control study
  • periprocedural complications

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this